Low-affinity conditions for agonists increase the binding of the antagonist [3H]RX821002 to the α(2B/C)-adrenoceptor subtypes in human brain and rat kidney

European Journal of Pharmacology

Volumn 332, Issue 1, 1997, Pages 109-112

  Callado, Luis F ^a   Meana, J Javier ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

2 Adrenoceptor subtype; Gpp(NH)p; Na+; RX821002 (2 methoxyidazoxan)

Indexed keywords

2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; EDETIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLYLIMIDODIPHOSPHATE; RADIOLIGAND; RECEPTOR SUBTYPE; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN; BRAIN CORTEX; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BRAIN; BRAIN CHEMISTRY; GUANYLYL IMIDODIPHOSPHATE; HUMANS; IDAZOXAN; KIDNEY; MALE; MEMBRANES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; TRITIUM;

EID: 0030740657     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01105-9     Document Type: Article

References (17)

1. 3H]rauwolscine. Eur. J. Pharmacol. 106, 141-147.
2. 2-adrenergic receptors. FASEB J. 6, 832-839.
3. 2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney. Eur. J. Pharmacol. 316, 359-368.
4. 3H]rauwolscine? A comparison of nine tissues and cell lines. J. Pharmacol. Exp. Ther. 273, 1287-1294.
5. 3H]RX821002. J. Pharmacol. Exp. Ther. 252, 312-319.
6. 3H]RX-821002 binding to membranes and tissue sections. Eur. J. Pharmacol. 310, 83-93.
7. 3H]raclopride binding to homogenates from human putamen and accumbens. Neurosci. Lett. 136, 79-82.
8. Hoffman, B.B., Lefkowitz, R.J., 1980. Radioligand binding studies of adrenergic receptors: New insights into molecular and physiological regulation. Annu. Rev. Pharmacol. Toxicol. 20, 581-608.
9. +, 5′-guanylylimidodiphostate, amiloride and ethylisopropylamiloride: Evidence for receptor G-protein precoupling. J. Pharmacol. Exp. Ther. 252, 1184-1196.
10. 2-adrenergic binding sites. Mol. Pharmacol. 37, 876-885.
11. 2-adrenergic receptor in membrane and solubilized preparations. Mol. Pharmacol. 21, 609-617.
12. 2-adrenoceptor subtypes. Br. J. Pharmacol. 109, 371-378.
13. + and guanine nucleotides. Nature 288, 709-711.
14. 3H-UK-14,304: Regulation by Gpp(NH)p and cations. Naunyn-Schmiedebergs Arch. Pharmacol. 336, 48-59.
15. Shi, A., Deth, R.C., 1994. Precoupling of alpha-2B adrenergic receptors and G-proteins in transfected PC-12 cell membranes: Influence of pertussis toxin and lysine-directed cross-linker. J. Pharmacol. Exp. Ther. 271, 1520-1527.
16. 3H-RX821002 ligand binding. Pharmacol. Toxicol. 69, 341-350.
17. Yeung, S.M.H., Green, R.D., 1983. Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5′-guanylylimidodiphosphate or N-ethylmaleimide. J. Biol. Chem. 258, 2334-2339.